EMUC audience

EMUC16: Re-thinking active surveillance strategies in PCa

With the emergence of more precise imaging and new results from genomic investigations, onco-urology experts are challenging standard medical strategies and are re-thinking their treatment regimens to achieve better patient care. At the concluding session of the 8th European...

EMUC16: Kidney cancer — from diagnosis to progression

Improving diagnosis and mapping out optimal treatment strategies for kidney cancer patients topped the second-day agenda of the 8th European Meeting on Urological Cancers (EMUC16) in Milan, Italy. The fourth plenary session focused on the challenges in kidney cancer...
podium noon

EMUC16: Imaging and the treatment landscape for recurrent PCa

Current and prospective treatment strategies that employ image-guided approaches for prostate cancer recurrences were examined with experts exploring options in radiotherapy, surgery and chemotherapy. Speakers Steven Joniau (BE), Barbara Jereczek-Fossa (IT), George Thalmann (CH) and Cora Sternberg (IT) presented...

Indolent cancers: The fine art of sophisticated pathology

Identifying patients with indolent cancers from those with aggressive disease are one of the many challenges faced by many doctors. Thus, the least visible specialist such as a pathologist could actually be holding the crucial key in diagnostic and...

EMUC15 Highlights

Highlights from the 7th European Multidisciplinary Meeting on Urological Cancers held in Barcelona, Spain. More here.

EMUC15: Challenges and developments in urological cancers

From diagnosis, systemic treatment to surgical management, experts and specialists in urological cancers assessed current practices and prospects while noting that the steady gains already achieved will hopefully lead to more optimal therapies. “Since 2007 when we had our...
Best unmoderated posters in bladder and kidney cancers

EMUC15: Best unmoderated posters in bladder and kidney cancers

The 7th EMUC has awarded today the three best unmoderated abstract posters to researchers from Italy, Israel and Belgium. Session chairpersons Profs. Bertrand Tombal and Harriet Thoeny cited the innovative approaches and insights on managing bladder and kidney cancers....
Prof. Susanne Osanto (NL) during a session on rare kidney cancers

EMUC15: Challenges in kidney cancers

There are notable gains in the diagnosis of uncommon renal tumours but patients need to be enrolled in clinical studies or referred to high-volume centres for researchers to reach more meaningful outcomes.   “Non-clear cell renal cell carcinoma (nccRCC)...
Winners best unmoderated posters at EMUC15

EMUC15: Prostate cancer studies win best unmoderated poster awards

Three studies in prostate cancer treatment have won the best unmoderated posters at the second day of the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15). Researchers in the Netherlands, Italy and a multi-centre study involving institutions in France...